Clinical Trial Update: Rivaroxaban Compared to Vitamin K Antagonist Upon Development of Cardiovascular Calcification [Phase 4]

View source ↗

Summary

Phase 4 trial comparing rivaroxaban to vitamin K antagonists in patients requiring long-term anticoagulation with cardiovascular calcification; study completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation
• Cardiovascular Calcification
• Coronary Calcification
• Pulmonary Embolism
• Valvular Calcification

Drugs mentioned

• Rivaroxaban (rivaroxaban)
• Vitamin K antagonist

Snippet

Sponsor: RWTH Aachen University | Conditions: Atrial Fibrillation or Pulmonary Embolism, Need of Long Term Oral Anticoagulation Therapy (OAT) | Phase 4 | Status: COMPLETED